CHNQD-01269
CHNQD-01269, a brefeldin A-cinnamate derivative, is an Arf1 inhibitor. CHNQD-01269 exhibits potent cytotoxic activity against HepG2 and BEL-7402 cells, with IC50 values of 0.29 and 0.84 μM, respectively. CHNQD-01269 is indicated for hepatocellular carcinoma (HCC) research.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 2648988-92-3
- 分子式: C27H35NO5
- 分子量:453.57
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Bel-7402 | IC50 |
0.84 μM
Compound: 33; CHNQD-01269
|
Antiproliferative activity against human Bel-7402 cells measured after 72 hrs by MTT assay
Antiproliferative activity against human Bel-7402 cells measured after 72 hrs by MTT assay
|
[PMID: 35849940] |
| HeLa | IC50 |
0.86 μM
Compound: 33; CHNQD-01269
|
Antiproliferative activity against human HeLa cells measured after 72 hrs by MTT assay
Antiproliferative activity against human HeLa cells measured after 72 hrs by MTT assay
|
[PMID: 35849940] |
| HepG2 | IC50 |
0.29 μM
Compound: 33; CHNQD-01269
|
Antiproliferative activity against human HepG2 cells measured after 72 hrs by MTT assay
Antiproliferative activity against human HepG2 cells measured after 72 hrs by MTT assay
|
[PMID: 35849940] |
| L02 | IC50 |
2.81 μM
Compound: 33; CHNQD-01269
|
Cytotoxicity against human L02 cells measured after 72 hrs by MTT assay
Cytotoxicity against human L02 cells measured after 72 hrs by MTT assay
|
[PMID: 35849940] |
| PANC-1 | IC50 |
0.64 μM
Compound: 33; CHNQD-01269
|
Antiproliferative activity against human PANC-1 cells measured after 72 hrs by MTT assay
Antiproliferative activity against human PANC-1 cells measured after 72 hrs by MTT assay
|
[PMID: 35849940] |
化学情報
-
CAS 番号 2648988-92-3
-
分子量 453.57
-
分子式 C27H35NO5
-
SMILES
CN(C)C(C=C1)=CC=C1/C=C/C(O[C@H]2[C@@]3([H])[C@@](/C=C/CCC[C@@H](OC(/C=C/2)=O)C)([H])C[C@@H](C3)O)=O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
プロトコル
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Liver Cancer Modeling
Liver cancer can be classified into primary liver cancer and secondary liver cancer. Secondary liver cancer is the metastatic liver cancer. Primary liver cancer includes hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC) and fibrolamellar HCC, of which HCC is the most common form, accounting for approximately 90% of primary liver cancers[1]. HCC mouse models include chemical agent-induced models, transplanted tumor models, and genetic engineered models.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)